This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07804/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07804/identifier/pubchem-compound/
n9http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB07804/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n13http://linked.opendata.cz/resource/drugbank/drug/DB07804/identifier/drugbank/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07804/identifier/chemspider/

Statements

Subject Item
n2:DB07804
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n9:DB07804 n14:DB07804
dcterms:title
5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE
adms:identifier
n7:99444275 n10:G15 n11:16040261 n12:13168809 n13:DB07804
n3:IUPAC-Name
n4:271B40C3-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B40C9-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B40C8-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B40C5-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B40C6-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B40C7-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B40C1-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B40BF-363D-11E5-9242-09173F13E4C5 n4:271B40C2-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B40C0-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B40CF-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B40D0-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B40CA-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B40CB-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B40CD-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B40CC-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B40CE-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B40D5-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B40D7-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B40D8-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B40D4-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B40D3-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B40D6-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B40C4-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B40D1-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B40D2-363D-11E5-9242-09173F13E4C5